Sarah Thomen, APRN
Family · Torrington, CTNPI 1811352560
Payments from drug & device makers
What this record shows
This record is dominated by education: $117 of the $117 with a category attached, or 100.0%. Lilly USA, LLC accounts for 89.8% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for family clinicians in CT, where the typical reported total is $257.
Across 2 payments — averaging $58.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$105
- Gilead$12
What the payments were for
- Education$117100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 1 | $105 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERZENIO$105
How this compares
$117 in reported general payments places this provider in the 30th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 22 | $356,423 |
| PomalystPomalidomide | 14 | $340,063 |
| JakafiRuxolitinib Phosphate | 14 | $236,183 |
| IbrancePalbociclib | 15 | $226,162 |
| CalquenceAcalabrutinib Maleate | 19 | $220,317 |
| Lenalidomide | 14 | $213,803 |
| BosulifBosutinib | 12 | $59,979 |
| Imatinib Mesylate | 11 | $26,973 |
| EliquisApixaban | 33 | $24,042 |
| XareltoRivaroxaban | 16 | $12,166 |
| Hydroxyurea | 99 | $2,663 |
| Moxifloxacin Hcl | 13 | $1,680 |
| Ondansetron OdtOndansetron | 34 | $1,443 |
| Acyclovir | 64 | $881 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $562 |
Paid to pharmacies, not to this prescriber.
Other family in Torrington
- David OhotnickyTorrington$24K
- Lisa HautTorrington$13K
- Brandy StepneyTorrington$10K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.